The Role of Nurse Practitioners in the Management of Heart Failure Patients and Programs

King-Dailey, Kathaleen; Frazier, Suzanne; Bressler, Sonya; King-Wilson, Jennifer

doi:10.1007/s11886-022-01796-0

Cited by 15 publications

(7 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…NPs, as licensed healthcare professionals, provide comprehensive, patient-centered care that improves patient self-care awareness and quality. Their roles include diagnosing and treating patients, prescribing medications, making referrals, managing acute and chronic conditions, and focusing on health promotion, disease prevention, and patient satisfaction [ 99 ]. A cohort study during the COVID-19 pandemic demonstrated that an NP-led pilot telehealth program enabled 75% of patients with HF to achieve optimal GDMT within 2 months, with a significant improvement in the left ventricular ejection fraction observed in 77% of patients during follow-up [ 100 ].…”

Section: Subgroups Of Patients With Hf and Gdmt Explorationmentioning

confidence: 99%

Advancing Guideline-Directed Medical Therapy in Heart Failure: Overcoming Challenges and Maximizing Benefits

Zhang,

Wang,

et al. 2024

Am J Cardiovasc Drugs

View full text Add to dashboard Cite

The delayed titration of guideline-directed drug therapy (GDMT) is a complex event influenced by multiple factors that often result in poor prognosis for patients with heart failure (HF). Individualized adjustments in GDMT titration may be necessary based on patient characteristics, and every clinician is responsible for promptly initiating GDMT and titrating it appropriately within the patient’s tolerance range. This review examines the current challenges in GDMT implementation and scrutinizes titration considerations within distinct subsets of HF patients, with the overarching goal of enhancing the adoption and effectiveness of GDMT. The authors also underscore the significance of establishing a novel management strategy that integrates cardiologists, nurse practitioners, pharmacists, and patients as a unified team that can contribute to the improved promotion and implementation of GDMT.

show abstract

Section: Subgroups Of Patients With Hf and Gdmt Explorationmentioning

confidence: 99%

Advancing Guideline-Directed Medical Therapy in Heart Failure: Overcoming Challenges and Maximizing Benefits

Zhang,

Wang,

et al. 2024

Am J Cardiovasc Drugs

View full text Add to dashboard Cite

show abstract

“…Initially, the increased thickness of the ventricular walls compensates for an increased workload. However, it can impair diastolic function over time and contribute to heart failure [14]. Systolic dysfunction, characterized by reduced ejection fraction, is a hallmark of HFrEF.…”

Section: Pathophysiologymentioning

confidence: 99%

Advancements in Heart Failure Management: A Comprehensive Narrative Review of Emerging Therapies

Sapna,

Raveena,

Chandio

et al. 2023

Cureus

View full text Add to dashboard Cite

Heart failure is a substantial and escalating global health challenge, affecting millions worldwide. This complex syndrome arises from diverse etiologies, encompassing ischemic heart disease, hypertension, valvular abnormalities, and cardiomyopathies. Heart failure is characterized by the heart's inability to pump blood efficiently to meet the body's metabolic demands, leading to debilitating symptoms, frequent hospitalizations, and high mortality rates. Traditionally, the management of Heart failure has focused on alleviating symptoms, reducing fluid retention, and enhancing cardiac contractility. These goals have been achieved through a combination of pharmacological therapies such as angiotensin-converting enzyme inhibitors, beta-blockers, and diuretics, often complemented by device-based interventions like implantable cardioverter-defibrillators and cardiac resynchronization therapy. However, despite these advances, the relentless progression of heart failure remains a significant clinical challenge. Neurohormonal activation, cardiac fibrosis, and cellular remodeling are just a few of the intricate processes contributing to the disease's progression. In recent years, researchers and clinicians have embarked on a quest to identify novel therapeutic approaches that address these underlying mechanisms. One such avenue of exploration involves the revolutionary field of gene therapy, with promising gene-editing techniques, such as CRISPR-Cas9, offering potential routes for correcting genetic mutations that contribute to heart failure. Additionally, regenerative medicine approaches, including stem cell therapy and tissue engineering, hold significant promise for repairing damaged cardiac tissue and restoring function. Furthermore, precision medicine initiatives have gained traction, aiming to tailor heart failure therapies to individual patient profiles, taking into account genetics, biomarkers, and comorbidities. Integrating artificial intelligence and machine learning in heart failure management has also enabled the development of predictive models for early intervention, risk stratification, and personalized treatment recommendations. This narrative review navigates the intricate landscape of emerging therapies for heart failure, emphasizing their potential to revolutionize the field by targeting the disease's fundamental mechanisms. By exploring these innovative approaches, we aspire to provide a comprehensive perspective on the evolving paradigm of heart failure management, fostering a hopeful outlook for patients and clinicians alike.

show abstract

“…Likewise, those who had radiation therapy for malignancies in the chest or middle of the chest are at risk of developing radiation-induced heart disease, which is marked by anomalies in the heart valves and the arteries that provide blood to the heart. Identifying these particular connections is essential for customizing surveillance and preventive measures to address the distinct cardiovascular risks linked to various cancer treatments [ 14 ].…”

Section: Reviewmentioning

confidence: 99%

“…Identifying groups of cancer patients who are at high risk for cardiovascular problems is crucial for implementing specific preventative measures and individualized healthcare strategies [ 14 ]. Multiple factors contribute to identifying individuals who are at a heightened risk of experiencing cardiovascular issues either during or after undergoing cancer therapy.…”

Section: Reviewmentioning

confidence: 99%

“…This method improves patient safety and leads to better cancer results and long-term cardiovascular health [ 13 ]. The dynamic field of cardio-oncology highlights the significance of continuous research and collaboration, ultimately influencing the future of tailored and comprehensive healthcare for patients dealing with the intricate overlap of cancer and cardiovascular conditions [ 14 ].…”

Section: Reviewmentioning

confidence: 99%

See 1 more Smart Citation

Cardio-Oncology: Managing Cardiovascular Complications of Cancer Therapies

Sharma,

Kashyap,

Olanrewaju

et al. 2023

Cureus

View full text Add to dashboard Cite

This narrative review explores the complex relationship between cancer medicines and cardiovascular health in the junction of oncology and cardiology, known as cardio-oncology. The study examines the historical development of cancer treatments and highlights the growing importance of cardiovascular problems in patient care. This text delves into the topic of cardiotoxicity, examining both conventional chemotherapeutic drugs like anthracyclines and more recent tyrosine kinase and immune checkpoint inhibitors. The complex molecular and cellular mechanisms that control cardiovascular problems are explained, including an understanding of how genetic predisposition influences an individual's sensitivity. The narrative expands into the crucial realm of risk stratification and evaluation, revealing advanced instruments for identifying cardiovascular risk in cancer patients. The importance of non-invasive imaging methods and biomarkers in early detection and continuous monitoring is emphasized.The prioritization of preventive tactics emphasizes the need to take proactive measures incorporating therapies to protect the heart throughout cancer treatment. It also highlights the significance of making lifestyle improvements to reduce risk factors. The narrative emphasizes the changing collaborative treatment environment, advocating for merging oncologists and cardiologists in a coordinated endeavor to maximize patient outcomes. In addition to clinical factors, the review explores the critical domain of patient education and support, acknowledging its crucial role in promoting informed decision-making and improving overall patient well-being. The latter portions of the text anticipate and consider upcoming treatments and existing research efforts that offer the potential for the future of cardio-oncology. This review seeks to provide a detailed viewpoint on the intricate connection between cancer treatments and cardiovascular well-being. Its objective is to encourage a more profound comprehension of the subject and prompt careful contemplation regarding the comprehensive care of cancer patients who confront the intricate difficulties presented by their treatment plans.

show abstract

The Role of Nurse Practitioners in the Management of Heart Failure Patients and Programs

Cited by 15 publications

References 44 publications

Advancing Guideline-Directed Medical Therapy in Heart Failure: Overcoming Challenges and Maximizing Benefits

Advancing Guideline-Directed Medical Therapy in Heart Failure: Overcoming Challenges and Maximizing Benefits

Advancements in Heart Failure Management: A Comprehensive Narrative Review of Emerging Therapies

Cardio-Oncology: Managing Cardiovascular Complications of Cancer Therapies

Contact Info

Product

Resources

About